.webp)
Bioculture for Pharmaceutical Wastewater Treatment
BactaServe Pharma is an acclimatised microbial formulation developed for biological treatment of pharmaceutical industry wastewater. It contains selected microbial species intended to support the treatment of biodegradable solvents, antimicrobial substances, microbicides and drug intermediates at low concentrations.
Supporting Biological Treatment of Pharmaceutical Wastewater
Pharmaceutical manufacturing generates wastewater with varying chemical compositions depending on the production process, raw materials and cleaning operations. Some wastewater streams may contain biodegradable solvents, antimicrobial substances, microbicides and drug intermediates that can affect biological treatment performance.
BactaServe Pharma is a specialised microbial formulation containing acclimatised microbial species suited to major pharmaceutical unit processes. It is designed to support the sustained and partial degradation of biodegradable process-related compounds present at low concentrations in pharmaceutical wastewater.
Key Benefits of BactaServe Pharma
BactaServe Pharma supports aerobic biological treatment of pharmaceutical wastewater with varying characteristics.
Acclimatised Microbial Species: Contains microbial species selected to suit major pharmaceutical unit processes.
Biodegradable Solvent Degradation: Supports the sustained and partial degradation of biodegradable solvents present in suitable wastewater streams.
Antimicrobial Substance Treatment: Supports biological treatment of wastewater containing antimicrobial substances at low concentrations.
Microbicide Degradation Support: Helps support the partial degradation of biodegradable microbicides under suitable treatment conditions.
Drug Intermediate Treatment: Supports the biological degradation of suitable drug intermediates present at low concentrations.
Application-Specific Treatment: Designed for pharmaceutical and related manufacturing sectors with different wastewater treatment requirements.
How BactaServe Pharma Works
Pharmaceutical wastewater can contain a mixture of organic compounds arising from manufacturing, formulation and cleaning processes. The biodegradability of these compounds varies, and some substances may affect the microorganisms responsible for biological treatment.
BactaServe Pharma contains acclimatised microbial species selected to suit major pharmaceutical unit processes. These microorganisms support the sustained and partial degradation of biodegradable solvents, antimicrobial substances, microbicides and drug intermediates present at low concentrations.
Its application is intended to support aerobic biological treatment where the wastewater constituents are suitable for microbial degradation. Treatment performance depends on wastewater composition, compound concentrations and operating conditions.
Applications of BactaServe Pharma
BactaServe Pharma is intended for aerobic biological treatment in pharmaceutical and related manufacturing industries.
Pharmaceutical Manufacturing: Supports biological treatment of suitable pharmaceutical process wastewater.
Nutraceutical Production: For aerobic treatment applications associated with nutraceutical manufacturing.
Formulations Manufacturing: Supports biological treatment of wastewater generated during formulation processes.
Parenteral Manufacturing: For suitable wastewater streams from parenteral production facilities.
Antibiotics and Drug Manufacturing: Supports treatment of wastewater containing biodegradable process-related compounds.
Speciality Drugs and Chemicals: For biological treatment applications involving speciality pharmaceutical products and chemicals.
New Chemical Entities (NCEs): Designed for consideration in wastewater treatment associated with NCE manufacturing processes.
Active Pharmaceutical Ingredients (APIs): Supports aerobic biological treatment of suitable wastewater generated during API production.
Suitable Wastewater Treatment Systems
BactaServe Pharma is intended for use in aerobic biological treatment processes serving pharmaceutical and related manufacturing facilities.
Aerobic Biological Treatment Units: For treatment systems using microorganisms under oxygenated conditions to degrade suitable organic compounds.
Industrial Effluent Treatment Plants (ETPs): For pharmaceutical ETPs treating wastewater from manufacturing and associated process operations.
The suitability of the product should be assessed against the existing treatment configuration and the composition of the wastewater stream.
Dosage and Application Procedure
BactaServe Pharma is prepared by mixing the product with feed water before dosing. The required daily quantity depends on wastewater volume and organic load.
Preparation Ratio: Mix 1 kg of BactaServe Pharma in 20 litres of feed water. For larger quantities, mix 2 kg in 40 litres of feed water.
Mixing: Mix the product thoroughly with the feed water.
Application: Dose the prepared mixture according to the detailed dosage schedule for the treatment system.
Daily Quantity: Determine the required amount based on wastewater volume and organic load.
Important Application Considerations
Pharmaceutical wastewater can vary significantly between manufacturing processes. Evaluating the wastewater characteristics is important when selecting a suitable biological treatment approach.
Wastewater composition: Identify the process-related compounds present in the wastewater stream.
Compound biodegradability: Assess whether the target solvents, antimicrobial substances, microbicides or drug intermediates are suitable for biological degradation.
Compound concentration: Consider the concentrations of target compounds, particularly where they are present at low levels.
Treatment process: Confirm suitability for the existing aerobic biological treatment system.
Organic loading: Consider wastewater volume and organic load when determining the required daily quantity.
Monitoring wastewater characteristics and treatment performance helps assess the suitability of the biological treatment approach.
Why Choose BactaServe Pharma?
BactaServe Pharma is an application-specific microbial formulation designed for aerobic biological treatment of pharmaceutical and related industrial wastewater.
Acclimatised Microorganisms: Contains microbial species selected for major pharmaceutical unit processes.
Specialised Wastewater Applications: Designed for pharmaceutical, nutraceutical, formulation, parenteral, API and related manufacturing sectors.
Target Compound Treatment: Supports the sustained and partial degradation of suitable biodegradable solvents, antimicrobial substances, microbicides and drug intermediates at low concentrations.
Aerobic Treatment Focus: Intended for use in suitable aerobic biological wastewater treatment processes.
Practical Dosing Preparation: Uses a defined product-to-feed-water mixing ratio, with the daily quantity determined by wastewater volume and organic load.
BactaServe Pharma can be considered for pharmaceutical wastewater treatment systems requiring support with the biological degradation of suitable process-related compounds. Assess the wastewater composition and treatment conditions to determine its suitability for the application.